Immune response of ponies to experimental infection with Ehrlichia equi.

The research investigates the immune response of ponies to an experimental infection of Ehrlichia equi, revealing a substantial cell-mediated immune response, high antibody titers, and resistance to re-infection following clinical ehrlichiosis.

Experimental Method

• Four ponies were experimentally infected with Ehrlichia equi, a bacterium that causes equine ehrlichiosis – a potentially serious tick-borne disease of horses.
• These ponies were monitored for both cell-mediated immune responses (how the body’s cells respond to pathogens) and serum anti-E equi antibody levels.
• In addition, two additional ponies were given convalescent blood or organ homogenates (a preparation of chemical extracts from body tissues) from ponies that had recovered from acute equine ehrlichiosis, treated with tetracycline, and then later exposed to E equi-infective blood.

Findings

• The infected ponies developed significant cell-mediated immune responses, as evidenced by the leukocyte migration-inhibition test. This test measures how effectively the body’s defensive white blood cells can move to an infection site.
• The levels of antibodies against E equi in the ponies’ blood serum rose to high levels. Antibodies are proteins produced by the immune system to neutralize harmful substances.
• The cell-mediated immune responses returned to baseline by day 200, but the antibody levels remained high for at least 300 days following initial inoculation, indicating a long-lasting immune response.
• The two additional ponies, which received blood or organ extracts from recovered ponies and then were exposed to E equi-infected blood, did not develop the clinical disease. This suggests that ponies that have recovered from equine ehrlichiosis may have an immunity to subsequent infections.

Implications

• The research suggests that ponies might develop resistance to reinfection with E equi after an initial bout of clinical ehrlichiosis. This could be important for prevention and treatment strategies.
• This immune response suggests that the body’s immune system recognizes the pathogen upon reinfection and launches an effective defense. This offers hope for the development of effective treatments or vaccines against this disease in the future.